glp-1 compounding crackdown news october 2025 FDA Intensifies on Compounded GLP-1s are entering a
Description
What do you think people would get if they are successful here
These are fundamentally different products serving different purposes, and some users may benefit from using both approaches simultaneously
The American Diabetes Association now recommends GLP-1 RAs for patients with established ASCVD regardless of their A1C and regardless of if the patient is taking metformin, the historically first line medication for T2DM [38]
Current medical recommendations for semaglutide & breastfeeding As mentioned, the research into the risks of taking semaglutide while breastfeeding is ongoing
The Rybelsus Summary of Product Characteristics notes that it can increase levothyroxine exposure
doi: 10.1124/pharmrev.123.001045
